No Data
No Data
H.C. Wainwright Maintains Reviva Pharmaceuticals(RVPH.US) With Buy Rating, Cuts Target Price to $14
H.C. Wainwright analyst Ram Selvaraju maintains $Reviva Pharmaceuticals(RVPH.US)$ with a buy rating, and adjusts the target price from $20 to $14.According to TipRanks data, the analyst has a success
Reviva Pharm Holdings Is Maintained at Buy by HC Wainwright & Co.
Reviva Pharm Holdings Is Maintained at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Maintains Buy on Reviva Pharmaceuticals, Lowers Price Target to $14
Express News | Reviva Announces Closing of $3 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
CUPERTINO, Calif., May 29, 2024 — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unm
Riviva Pharmaceuticals Prices $3 Million Offering of Stock, Warrants; Shares Slump
Reviva Pharmaceuticals (RVPH) declined by more than 8% in early trading Tuesday after the late-stage drug maker priced an offering of nearly 1.9 million shares and warrants to buy an equal number of s
No Data
Jaguar8 : Sad story
TrytosaveabitOP Jaguar8: Yup yup